Author: Ekawat Pasomsub; Siriorn P. Watcharananan; Kochawan Boonyawat; Pareena Janchompoo; Garanyuta Wongtabtim; Worramin Suksuwan; Somnuek Sungkanuparph; Angsana Phuphuakrat
Title: Saliva Sample as a Non-Invasive Specimen for the Diagnosis of Coronavirus Disease-2019 (COVID-19): a Cross-Sectional Study Document date: 2020_4_22
ID: 0bbzo9cp_16
Snippet: The study had several strengths. We prospectively collected data on consecutive 173 patients who were at high risk of COVID-19 infection including those with acute respiratory 174 symptoms and having risk factors, thus minimizing potential spectrum effect. All enrolled 175 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the autho.....
Document: The study had several strengths. We prospectively collected data on consecutive 173 patients who were at high risk of COVID-19 infection including those with acute respiratory 174 symptoms and having risk factors, thus minimizing potential spectrum effect. All enrolled 175 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- acute respiratory include and risk factor: 1, 2, 3, 4
- acute respiratory include infection and high risk: 1
- cc NC ND International license and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cc NC ND International license and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- high risk and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- high risk and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- International license and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- potential spectrum effect and spectrum effect: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date